-
-
-
-
-
-
-
Takeda and Protagonist Announce U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Rusfertide as a Potential First-in-Class Therapy for Polycythemia Vera
-
-
-
-
-
-
-
Takeda and HUTCHMED Announce New Drug Application (NDA) for Fruquintinib for Treatment of Previously Treated Metastatic Colorectal Cancer Granted Priority Review
-
-
-
-
-
15,971 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


